Table of Contents November 04, 2014; Volume Issue supplement 1

  1. Aach, Til

    1. Clinical evaluation of a new low dose Tc-rest, Tl-stress single-scan cardiac SPECT protocol indicating improved accuracy
      Thomas Dey, Barbra Backus, Herfried Wieczorek, Til Aach and Fred Verzijlbergen
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1867;
    2. Fast convergence and low noise in time-of-flight PET reconstruction - Analytical theory and Monte Carlo simulation
      Thomas Dey, Herfried Wieczorek, Andre Salomon, Andreia Trindade and Til Aach
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 157;

  2. Aarsvold, John

    1. Initial testing of a unique, high-resolution, cardiac SPECT system
      James Galt, Jack Juni, John Aarsvold and Fabio Esteves
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 438;

  3. Abbas, Ahmed

    1. Assessment of myocardial blood flow using 3D [15O]-H2O PET/CT: Analytic or iterative reconstruction?
      Jean-Simon Arnould, Alban Bailliez, Tanguy Blaire, Denis Agostini, Ahmed Abbas and Alain Manrique
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 294;

  4. Abbruzzese, Bonnie

    1. Correlation of preoperative lymphoscintigraphy with in vivo lymphatic mapping in Phase 3 breast cancer & melanoma clinical studies employing a receptor-targeted (CD206) ILM agent, Tc99m-tilmanocept
      Frederick Cope, Wendy Metz, Simon Blackburn, Bonnie Abbruzzese, Jo Shuping, Michael Blue, Beth Potter, Lori Christman and Dennis King
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1280;
    2. Receptor targeted (CD206) Tc99m-tilmanocept (TIL) provides for enhanced long-term (>24 hr) stable signal localization in lymph nodes and equally stable concordance with early preoperative imaging in melanoma and breast cancer (M/BC)
      Wendy Metz, Frederick Cope, Simon Blackburn, Bonnie Abbruzzese, Jo Shuping, Michael Blue, Beth Potter, Lori Christman and Dennis King
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 278;

  5. Abdelmalik, Amir

    1. Role of FDG PET/CT in prediction of post-radiation therapy chest wall toxicity
      Kurt Hammann, Sherry Bicklein, Crystal Botkin, William Hubble, John Dombrowski, Amir Abdelmalik and Medhat Osman
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2721;
    2. Pituitary adenoma: Incidentaloma identified by F18-FDG PET/CT
      Amir Abdelmalik, Lejla Sarajlic, Razi Muzaffar and Medhat Osman
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 101;
    3. Is the prognosis different between lung cancer with and without cavitary feature? A retrospective FDG PET/CT study
      Samuel Nyon, Kumar Abhishek, Amir Abdelmalik, Medhat Osman and Nghi Nguyen
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1392;
    4. Pictorial essay: Ophthalmologic abnormalities in FDG PET/CT
      Razi Muzaffar, Patricio Fajnwaks, Lejla Sarajlic, Amir Abdelmalik and Medhat Osman
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1054;
    5. The incremental added value of including the head in the imaged field of view: A retrospective evaluation of 8431 18F-FDG PET/CT studies
      Lejla Sarajlic, Crystal Botkin, William Hubble, Amir Abdelmalik and Medhat Osman
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2719;

  6. Abdolell, Mohamed

    1. Comparison of PET-CT tumor burden parameters with proven prognostic markers in patients with diffuse large B-cell lymphoma
      Jason Fong, Matthew Bligh, David MacDonald, Mohamed Abdolell and Steven Burrell
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1370;

  7. Abe, Koichiro

    1. The clinical usefulness of partial volume effect corrected FDG-PET/CT for the prediction of I-131 accumulation in metastatic lymph nodes during I-131 therapy for patients with papillary thyroid carcinoma
      Yasuhiro Maruoka, Koichiro Abe, Shingo Baba, Takuro Isoda, Masayuki Sasaki and Hiroshi Honda
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2036;
    2. Variability of size-collected pretreatment FDG uptake predicts prognosis of patients with diffuse large cell lymphoma
      Shingo Baba, Koichiro Abe, Takuro Isoda, Yasuhiro Maruoka, Masayuki Sasaki and Hiroshi Honda
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1375;
    3. The efficacy of FDG-PET/CT for the differentiation of autoimmune pancreatitis from pancreatic cancer
      Koichiro Abe, Shingo Baba, Takuro Isoda, Yasuhiro Maruoka, Masayuki Sasaki and Hiroshi Honda
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1323;
    4. The influences of point-spread-function and time-of-flight on SUV of lymph node metastasis in FDG-PET
      Go Akamatsu, Katsuhiko Mitsumoto, Takafumi Taniguchi, Isao Komiya, Nobuyoshi Ohya, Koichiro Abe, Shingo Baba and Masayuki Sasaki
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2509;
    5. Prediction of tumor response to chemoradiation with coefficient of variation of FDG uptake in metastatic lymph nodes in the patients with pharyngeal cancer
      Takuro Isoda, Koichiro Abe, Shingo Baba, Yasuhiro Maruoka, Tadamasa Yoshitake, Katsumasa Nakamura, Masayuki Sasaki and Hiroshi Honda
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1349;

  8. Abe, Takahiro

    1. FMISO PET correlates with the expression of HIF-1α in oral squamous cell carcinoma
      Jun Sato, Kitagwa Yoshimasa, Yutaka Yamazaki, Hironobu Hata, Takahiro Abe, Tetsuya Kitamura, Naoya Hattori, Tohru Shiga, Masanobu Shindoh and Nagara Tamaki
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 390;
    2. FMISO PET reflects the pathological findings with cervical lymph node metastasis in oral squamous cell carcinoma
      Jun Sato, Yoshimasa Kitagawa, Yutaka Yamazaki, Hironobu Hata, Takahiro Abe, Tetsuya Kitamura, Naoya Hattori, Tohru Shiga, Masanobu Shindoh and Nagara Tamaki
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 392;
    3. Value and limitation of preoperative lymph node staging using FDG PET/CT in patients with oral cancer: Comparison with histological findings
      Masaaki Miyakoshi, Chika Murai, Takahiro Abe, Hironobu Hata, Akira Sato, Yutaka Yamazaki, Kitagwa Yoshimasa, Tohru Shiga and Nagara Tamaki
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1347;
    4. Usefulness of FDG-PET in diagnosing and monitoring for refractory osteonecrosis of jaws
      Yoshimasa Kitagawa, Makiko Kyan-Onodera, Hironobu Hata, Takahiro Abe, Jun Sato, Yutaka Yamazaki, Naoya Hattori, Tohru Shiga, Yuji Kuge and Nagara Tamaki
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2163;

  9. Abele, Jonathan

    1. Parathyroid adenoma localized on dual phase Tc-99m MIBI imaging with SPECT/CT: A comparison of length of hospital stay for patients treated with minimally invasive parathyroidectomy versus conventional neck dissection
      Christopher Fung, Wade Koberstein, Kristy Romaniuk and Jonathan Abele
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 2041;
    2. A cost-efficient diagnostic imaging algorithm incorporating I-123 MIBG SPECT/CT for suspected pheochromocytoma
      Michael Stamm and Jonathan Abele
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 474;

  10. Abendschein, Dana

    1. Nanoparticle PET imaging of natriuretic peptide clearance receptor in a rabbit atherosclerosis model
      Yongjian Liu, Eric Pressly, Luke Connal, Hannah Luehmann, Annie Nguyen, Dana Abendschein, Craig Hawker, Pamela Woodard and Michael Welch
      Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1789;
« Previous (Pages : 1 2 3 4 5 6 ... 689) Next »
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
Sign up for alerts